Vape Industry Weekly: August Week 1 – Top 7 Stories

The week of July 27 to August 2 saw regulatory pressure intensify across three continents. China’s tobacco regulator summoned Elf Bar’s parent company over compliance breaches, while Vietnam’s government formally endorsed a comprehensive ban on all new nicotine products. In the United States, a federal appeals court upheld Iowa’s e-cigarette law, and Philip Morris opened a $1.2 billion ZYN manufacturing campus in Colorado. EU member states pushed back against Ireland’s nicotine restrictions, BAT reported surging oral product growth, and a Canadian court certified a nationwide class action against Juul and Altria.

1. China’s Tobacco Regulator Summons iMiracle Over Compliance Breaches

China’s State Tobacco Monopoly Administration (STMA) summoned iMiracle — the parent company of Elf Bar and EBDesign — over suspected regulatory violations. iMiracle is one of the world’s largest disposable vape manufacturers, and the summons signals that Beijing is tightening oversight of its domestic e-cigarette industry. This follows China’s earlier moves to eliminate VAT export rebates for e-cigarettes and address industry overcapacity. The action could disrupt global disposable vape supply chains if enforcement leads to production restrictions. Read our coverage of China’s broader e-cigarette industry controls and the 6-methyl nicotine enforcement gap.

2. 8th Circuit Upholds Iowa E-Cigarette Law

The U.S. 8th Circuit Court of Appeals reversed a lower court’s block on Iowa’s e-cigarette regulatory law, ruling that the state’s requirements do not conflict with federal FDA regulations. The decision clears the path for Iowa to enforce product registration and state-level oversight. The 8th Circuit covers seven states — Arkansas, Iowa, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota — setting a regional precedent. The ruling contrasts with the 5th Circuit’s skepticism toward FDA vape authorization logic, showing that federal-state regulatory tensions play out differently across circuits. We published a full analysis of the 8th Circuit Iowa ruling, and readers can compare it with Hawaii’s FDA registry model.

3. Vietnam Government Endorses Comprehensive Nicotine Ban

Vietnam’s government formally endorsed Resolution No. 160/NQ-CP, which bans the production, trading, storage, transport, advertising, and use of e-cigarettes, heated tobacco products, and novel nicotine products including pouches. Health officials argued that a sale-only ban would be insufficient given rising youth use. The amended Law on Prevention and Control of Tobacco Harms will define regulated products and enforcement responsibilities. Vietnam’s National Assembly had already voted to ban e-cigarette business from 2026, and this resolution expands the scope to cover nicotine pouches. See our earlier reporting on Vietnam’s enforcement framework.

4. Philip Morris Opens $1.2B ZYN Manufacturing Campus

Philip Morris International inaugurated a $1.2 billion manufacturing campus in Aurora, Colorado dedicated to ZYN nicotine pouches. The facility brings 500 direct jobs and represents one of the largest single-product manufacturing investments in the oral nicotine category. The expansion comes after the FDA granted ZYN modified risk tobacco product (MRTP) status — a first for nicotine pouches. PMI is betting that oral nicotine will be a dominant growth driver, and the scale of this investment signals confidence in regulatory stability for the category. Read about FDA’s ZYN MRTP authorization and how New York’s 75% pouch tax creates a contrasting headwind.

5. EU Countries Challenge Ireland’s Nicotine Bill

Italy and Greece submitted formal objections under the EU’s Technical Regulation Information System (TRIS) against Ireland’s proposed nicotine product regulations. Ireland’s bill would ban non-tobacco flavors, introduce plain packaging, restrict retail and online displays, and extend measures to nicotine pouches. Both countries argued the proposals could create trade barriers and conflict with the EU’s ongoing TPD revision. Italy questioned proportionality, suggesting less restrictive alternatives like stronger age verification. The standstill period extends to October 7, giving Ireland time to revise or withdraw the bill. This mirrors the pushback Poland faced over its flavor ban, where Sweden, Romania, Slovakia, and Greece objected. See our coverage of the EU Parliament’s rejection of nicotine tax proposals.

6. BAT Reports H1 Growth as New Categories Surge 18%

British American Tobacco reported H1 2026 revenue of £12.24 billion, up 1.4% reported and 2.9% at constant currency. New Categories revenue jumped 18% to £1.93 billion, driven by Modern Oral growth of 65.9% and a return to double-digit U.S. Vapor growth. Smokeless products now reach 35 million consumers and account for 19.8% of group revenue. BAT plans a national rollout of Velo Max and selected Vuse flavors in H2. The results show that despite regulatory pressure, the smoke-free transition is accelerating for major tobacco companies. This contrasts with the UK market where disposable vape bans are reshaping retail.

7. Canadian Court Certifies Class Action Against Juul and Altria

The Supreme Court of British Columbia certified a nationwide class action against Juul Labs and Altria Group, allowing claims on behalf of Canadians who purchased or used Juul products between August 2018 and July 2026. The lawsuit alleges the companies marketed e-cigarettes as safer alternatives while contributing to nicotine addiction. The ruling is procedural and does not determine liability. Juul and Altria may appeal. This follows a parallel U.S. antitrust case where Altria and Juul are asking the 9th Circuit to overturn class certification. We published a full article on the Canadian class action certification.

Weekly Trends & Analysis

Three patterns emerged this week. First, China is moving from passive regulation to active enforcement. The STMA summons of iMiracle — combined with earlier VAT rebate eliminations and overcapacity controls — shows Beijing intends to rein in its domestic vape industry, not just export it. If enforcement tightens further, global disposable vape supply chains will feel the impact. Second, EU member states are pushing back against national-level nicotine restrictions that go beyond EU frameworks. Italy, Greece, Sweden, Romania, and Slovakia have all filed objections against either Ireland’s or Poland’s proposed bans, arguing proportionality and trade barrier concerns. This resistance suggests the EU’s TPD revision will face a difficult balancing act between public health ambition and single-market coherence. Third, major tobacco companies are accelerating their smoke-free transitions. PMI’s $1.2 billion ZYN investment and BAT’s 18% New Categories growth both signal that oral nicotine is becoming the primary battleground — not vaping. The contrast between regulatory hostility toward vapes and regulatory acceptance of pouches (FDA MRTP for ZYN, BAT’s Velo expansion) is creating a clear divergence in the reduced-risk product market.

What to Watch Next Week

– Pyxus International Q1 FY2027 earnings (Aug 5): First look at the tobacco leaf supplier’s performance under shifting nicotine demand.
– Universal Corporation fiscal Q1 results (Aug 6): Another indicator of tobacco supply chain dynamics.
– Ireland’s response to EU objections: Whether Ireland revises, delays, or proceeds with its nicotine bill before the October 7 standstill expires.
– China iMiracle follow-up: Any enforcement action or public statement from STMA could signal broader crackdown intent.
– Poland’s flavor ban standstill (Nov 6 deadline): Watch for additional EU member state objections or a Polish withdrawal.